
New Alzheimer’s Pill Shows Promise in Slowing Brain Decline
A Lancaster County family benefits from new FDA-approved Alzheimer's drugs, Leqembi and Kisunla, which target amyloid protein buildup in the brain, offering hope for slowing disease progression and improving quality of life, with local health systems expanding access and research.
